PubMed (GeneRIF) for id: 10406

Year	Number of Results
2003	1
2005	1
2006	1
2007	1
2008	2
2009	4
2010	4
2011	12
2012	27
2013	17
2014	25
2015	20
2016	27
2017	15
2018	17
2019	22
2020	18
2021	13
2022	10
2023	8
2024	3

1

Human Epididymis Protein 4 (HE4) and Cancer Antigen 125 (CA125) for Prediction of Optimal Primary Surgery in Non-Mucinous Epithelial Ovarian Cancer.

Promchit K, Oranratanaphan S. Promchit K, et al. Asian Pac J Cancer Prev. 2024 Jan 1;25(1):281-286. doi: 10.31557/APJCP.2024.25.1.281. Asian Pac J Cancer Prev. 2024. PMID: 38285795 Free PMC article.

2

Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in comparison to CA125.

AlSomairi A, Himayda S, Altelmesani A, Lee YJ, Lee JY. AlSomairi A, et al. Gynecol Oncol. 2024 Feb;181:155-161. doi: 10.1016/j.ygyno.2023.12.021. Epub 2024 Jan 3. Gynecol Oncol. 2024. PMID: 38176127

3

Elevated level of serum human epididymis protein 4 (HE4) predicts disease severity and mortality in COVID-19 pneumonia.

Sütő R, Pócsi M, Szabó Z, Fejes Z, Ivády G, Kerekes G, Fagyas M, Nagy A, Szentkereszty Z, Kappelmayer J, Nagy B Jr. Sütő R, et al. BMC Pulm Med. 2023 Dec 16;23(1):512. doi: 10.1186/s12890-023-02811-y. BMC Pulm Med. 2023. PMID: 38104063 Free PMC article.

4

Combination of serum CST1 and HE4 for early diagnosis of endometrial cancer.

Zhong W, Liu Y, Zhang L, Zhuang W, Chen J, Huang Z, Zheng Y, Huang Y. Zhong W, et al. PeerJ. 2023 Dec 5;11:e16424. doi: 10.7717/peerj.16424. eCollection 2023. PeerJ. 2023. PMID: 38077439 Free PMC article.

5

Serum human epididymis protein 4 is associated with disease severity in patients with IgA nephropathy.

Luo HL, He C, Xue H, Li M, Ji L, Xia Y. Luo HL, et al. Clin Biochem. 2024 Jan;123:110701. doi: 10.1016/j.clinbiochem.2023.110701. Epub 2023 Dec 2. Clin Biochem. 2024. PMID: 38048899

6

Diagnostic value of serum human epididymis protein 4, carbohydrate antigen 125 and their combination in endometrial cancer: A meta-analysis.

Wu Q, Bai SN, Song LY, Wu WF, Han LN. Wu Q, et al. Medicine (Baltimore). 2023 Aug 18;102(33):e34737. doi: 10.1097/MD.0000000000034737. Medicine (Baltimore). 2023. PMID: 37603503 Free PMC article.

7

Effect of Serum Level of Human Epididymis Protein 4 and Interleukin-6 as Biomarkers in Patients with Adnexal Mass.

Hameed S, Abdulqader Jasim H, Sharief M. Hameed S, et al. Arch Razi Inst. 2022 Oct 31;77(5):1659-1671. doi: 10.22092/ARI.2022.358329.2194. eCollection 2022 Oct. Arch Razi Inst. 2022. PMID: 37123162 Free PMC article.

8

Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma.

Li J, Li J, Hao H, Lu F, Wang J, Ma M, Jia B, Zhuo M, Wang J, Chi Y, Zhai X, Wang Y, Wu M, An T, Zhao J, Yang F, Wang Z. Li J, et al. BMC Cancer. 2023 Jan 31;23(1):110. doi: 10.1186/s12885-023-10523-z. BMC Cancer. 2023. PMID: 36721112 Free PMC article.

9

The Utility of Preoperative Serum CA125 Combined with HE4 to Predict Lymph Node Metastasis in Endometrial Cancer.

Prueksaritanond N, Angsathapon S, Insin P. Prueksaritanond N, et al. Gynecol Obstet Invest. 2023;88(1):53-60. doi: 10.1159/000528851. Epub 2023 Jan 3. Gynecol Obstet Invest. 2023. PMID: 36596280

10

Human epididymis protein 4 as a clinical biomarker in identifying interstitial lung disease in patients with idiopathic inflammatory myopathies.

Sun F, Zhao J, Li Y, Wang H, Cao X, Cheng W, Chen J. Sun F, et al. Int Immunopharmacol. 2023 Feb;115:109609. doi: 10.1016/j.intimp.2022.109609. Epub 2022 Dec 26. Int Immunopharmacol. 2023. PMID: 36577160

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

213 results

Results by year